Jon Hamilton
Stories
-
Health
More U.S. Travelers Are Flying Again Despite COVID-19 Risks
Friday marked the busiest day for the nation's airports since COVID-19 put the brakes on air travel almost a year ago. But the number of travelers remains far below 2019 levels.
-
Health
'Providers Don't Even Listen': Barriers To Alzheimer's Care When You're Not White
Nonwhite Americans looking for care for a loved one are much more likely than whites to encounter discrimination, language barriers, and providers who lack cultural competence, a new report finds.
-
Science
What A Brain Organoid Grown With Neanderthal DNA Tells Us About Modern Humans
A brain organoid grown with Neanderthal DNA reveals how evolution shaped the brains of modern humans and adds to evidence that brain differences helped us survive while our human cousins went extinct.
-
Health
How COVID-19 Attacks The Brain And May Cause Lasting Damage
Severe cases of COVID-19 can injure the brain in ways that affect memory, thinking and mood for months after the infection is gone, new research hints. It may even raise the risk of Alzheimer's.
-
Health
Progress Toward A Safer Psychedelic Drug To Treat Depression And Addiction
A synthetic version of the psychedelic drug ibogaine appears to relieve depression and addiction without producing hallucinations or other dangerous side effects — at least in rodents.
-
Health
Government Model Suggests U.S. COVID-19 Cases Could Be Approaching 100 Million
Government scientists estimate that the true number of coronavirus infections is eight times the reported number of 12.5 million, meaning "most of the country remains at risk," the team reports.
-
Health
FDA Approves First Drug For A Rapid Aging Disorder In Children
A newly approved drug can extend the lives of children with progeria, a rare disorder that causes rapid aging. The drug is the result of one family's effort to help a child with the fatal condition.
-
Science
FDA Approves First Drug For Rare, Rapid-Aging Genetic Disorder
The Food and Drug Administration has approved a treatment for progeria, a genetic disorder that causes children to age rapidly. Zokinvy is the first drug approved by the agency for the disorder.
-
National
Deep Sleep Protects Against Alzheimer's, Growing Evidence Shows
People who get more deep sleep appear less likely to develop Alzheimer's. That may be because this phase of sleep allows the brain to clear out waste products.
-
National
FDA Advisory Panel Rejects Controversial Alzheimer's Drug
A Food and Drug Administration advisory committee voted that studies of the drug aducanumab for Alzheimer's treatment don't show it's effective.